Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2022-04-30
2022-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VR Relaxation in Older Adults With Mental Illness
NCT06973941
Three-dimensional Virtual Reality and Hands-on Aromatherapy
NCT04324216
Mindfulness Meditation in Older Adults
NCT01532596
VR Mindfulness Study
NCT05592782
Compassion Meditation for Older Adults
NCT03964246
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention: Virtual Reality Mindfulness Group
The intervention will be 4-weeks, twice per week, 15-minute/session VR-mindfulness intervention group.
VR Meditation
This 4-week VR program will use the Oculus Pro-Quest 2 headsets for the 15-minute seated VR meditation twice per week for a total of 8 sessions over the 4 weeks.
No intervention: Waitlist Control Group
These participants will be on a waitlist to receive the VR guided meditation program after data collection has been completed (after the 4 weeks)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VR Meditation
This 4-week VR program will use the Oculus Pro-Quest 2 headsets for the 15-minute seated VR meditation twice per week for a total of 8 sessions over the 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Perceived Stress Score (PSS)equal or greater than 10
* Over \>=60 years of age
Exclusion Criteria
* History of recurrent migraines or seizures or TBI in the past year
* Substance use disorders in the last year
* Psychiatric hospitalizations in the last year.
* Acute psychotic symptoms
* Acute suicidal ideation or intent
* Glaucoma
* PTSD
* Changes to psychoactive medications in the past 4 weeks
* Alcohol, caffeine or cannabis consumption within 24 hr before the session, or nicotine consumption within 15 min of the session
* Important hearing impairment
* Recovery phase of any eye surgery
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lady Davis Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soham Rej MD, MSc
Primary Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Douglas Mental Health University Institute
Montreal, Quebec, Canada
Lady Davis Institute/ Jewish General Hospital
Montreal, , Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cinalioglu K, Lavin P, Bein M, Lesage M, Gruber J, Se J, Bukhari S, Sasi N, Noble H, Andree-Bruneau M, Launay C, Sanders J, Gauthier S, Rosa P, Lifshitz M, Battistini BJ, Beauchet O, Khoury B, Bouchard S, Fallavollita P, Vahia I, Rej S, Sekhon H. Effects of virtual reality guided meditation in older adults: the protocol of a pilot randomized controlled trial. Front Psychol. 2023 Jul 28;14:1083219. doi: 10.3389/fpsyg.2023.1083219. eCollection 2023.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IUSMD-21-48
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.